NCT05324631

A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Non-Radiographic Axial Spondyloarthritis

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Clinical Study to Evaluate the Efficacy and Safety of SHR0302 in Active Non-Radiographic Axial Spondyloarthritis Subjects

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 300 (estimated)
• Sponsor: Jiangsu HengRui Medicine Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This study is to evaluate the efficacy and safety of SHR0302 in subjects with active non-radiographic axial spondyloarthritis.

Conditions

• Non-radiographic Axial Spondyloarthritis

Interventions

Type	Name	Description
DRUG	SHR0302	SHR0302, oral, once daily
DRUG	SHR0302 placebo	SHR0302 placebo, oral, once daily

Timeline

• Start date: 2022-08-16
• Primary completion: 2024-08-30
• Completion: 2024-12-11
• First posted: 2022-04-12
• Last updated: 2022-09-02

Locations

1 site across 1 country: China